Intrinsic Value of S&P & Nasdaq Contact Us

Centessa Pharmaceuticals plc CNTA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • GB • USD

SharesGrow Score
33/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$38.60
-2.5%

Stock Statistics — CNTA

Centessa Pharmaceuticals plc (CNTA) has a market capitalization of $5.91B and trades at $39.59. The 52-week range is 9.6-40.26.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -27.1, Earnings Per Share (EPS) of $-1.46, annual revenue of $15M.

The stock has a beta of 1.55, operates in the Healthcare sector.

Trading Data
Current Price$39.59
52-Week Range9.6-40.26
Volume6.22M
Avg Volume (30D)2.5M
Market Cap$5.91B
Beta (1Y)1.55
Company
IPO Date2021-05-28
Employees77
CEOMario Alberto Accardi
CountryGB
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS1523091007
CUSIP152309100
Income (Latest Year)
Revenue$15M
Gross Profit$15M
EBITDA$-207.69M
Operating Income$-207.69M
Net Income$-197.53M
EPS$-1.46
EPS Diluted$-1.46
Shares Outstanding$135.72M
Balance Sheet (Latest Year)
Total Assets$687.5M
Current Assets$367.88M
Cash & ST Investments$294.58M
Total Liabilities$160.63M
Total Debt$7.57M
Net Debt$-53.73M
Total Equity$526.86M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-27.1
P/S Ratio393.86
P/B Ratio11.21
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message